Latest News | Concord Biotech Shares Rally over 21 Pc in Debut

New Delhi, Aug 18 (PTI) Shares of Concord Biotech listed with a premium of over 21 per cent against the issue price of Rs 741 on Friday.

The stock began the trade at Rs 900.05, registering a jump of 21.46 per cent against the issue price on the BSE. Later, it zoomed 23.61 per cent to Rs 916.

Also Read | Indian Rocket Startup Astrophel Aerospace Successfully Test Fires Prototype Cryogenic Engine.

At the NSE, it listed at Rs 900.05 and further rallied 23.73 per cent to Rs 916.90.

The company commanded a market valuation of Rs 9,447.89 crore.

Also Read | Uttar Pradesh Horror: Man Tries to Cut Off Own Head With Electric Saw to ‘Appease’ Lord Shiva in Lalitpur, Condition Critical.

The Initial Public Offer (IPO) of Concord Biotech was subscribed 24.86 times last week.

The Rs 1,550.59 crore initial share-sale had a price range of Rs 705-741 a share.

Rare Enterprises-backed Concord Biotech's IPO was entirely an Offer For Sale (OFS).

Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, anti-fungal and anti-bacterial.

The company, which has 23 API products, has three manufacturing facilities at Valthera, Dholka, and Limbasi, in Gujarat.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)